Skip to content
Open access

Pharmacologic Targeting of ZNF281 Suppresses Metastatic Prostate Cancer Beyond Androgen Receptor Dependence

Sep 2026 · bioRxiv · 0 citations · 59 references
Biology

TL;DR

This study reveals the previously uncharacterized of ZNF281 in promoting androgen receptor–dependent transcription and androgen receptor-independent proliferative and metastatic programs in prostate cancer, advances understanding of disease progression across different androgen receptor expression statuses, and establishes pharmacologic ZNF281 inhibition as a therapeutic strategy for metastatic prostate cancer.

Read PDF

Similar papers

Open access Sep 2026

Loss of NCOA6 protein causes aggressive prostate cancer with EGFR overexpression and dependency

Loss of tumor suppressors can drive carcinogenesis while simultaneously creating actionable therapeutic vulnerabilities. Epidermal growth factor receptor (EGFR) is frequently overexpressed in prostate cancer (PCa), yet EGFR inhibitors have shown limited clinical benefit, and the basis for this variability remains uncle...

Yong-Hong Liu, Zhang-Wei Tong, Q. Mo et al. · 0 citations
Open access Sep 2026

Androgen receptor condensates drive gastric cancer through SWI/SNF-mediated chromatin remodeling and create a therapeutic vulnerability

These findings establish AR phase separation as a fundamental mechanism driving GC pathogenesis and propose co-targeting AR condensates and chromatin remodeling as a translatable therapeutic strategy.

Hua-Huan Liu, Yan-Xin Yao, Xiang-Nan Zhang et al. · 0 citations
Open access Sep 2026

Follistatin drives AR-independent prostate cancer through BMP signaling inactivation and microenvironmental remodeling.

FST-Trap is developed, which effectively neutralizes FST, resensitizes resistant tumors to AR-targeted therapy, and enhances immunotherapy efficacy, establishing FST as both a biomarker and therapeutic target for AR-independent prostate cancer.

Xiao-Xian Shi, Zu-Yan Fan, Min Qu et al. · 0 citations
Open access Aug 2026

Vitronectin Enrichment in Prostate Cancer Liver Metastases Promotes Adhesion and Survival

Abstract The development of liver metastases in prostate cancer is associated with aggressive disease and poor prognosis. Because hepatocytes exhibit high metabolic activity with unique secretory profiles, we hypothesized that hepatocyte-to-tumor cell signaling plays a role in promoting liver metastasis. We evaluated s...

Jacob Egelberg, Rebecca Kim, M. J. Kim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.